Cellebrite DI : CLBT FY26 Q2 Historical Financial Tables and Supplemental Data

About this update from Cellebrite Di Ltd.

Investor Kit Second Quarter 2026 FY 2023 Yr Ended 31-Dec $ 271,028 82,007 353,035 17,285 30,883 401,203 26,004 -16,200 20,389 62,593 338,610 98,415 132,389 50,900 - 281,704 56,906 (332,890) (275,984) 7,023 $ (283,007) $ (1.35) $ (1.35) 209,471,827 209,471,827 84.4% 24.5% 33.0% 12.7% 70.2% 14.2% -2.5% -70.5% FY 2024 Yr Ended 31-Dec $ 330,765 96,245 427,010 17,771 30,894 475,675 37,461 87 15,617 22,007 75,172 400,503 113,877 154,814 65,332 - 334,023 66,480 24,198 90,678 12,352 $ 78,326 $ 0.32 $ 0.31 241,626,316 249,903,126 84.2% 23.9% 32.5% 13.7% 70.2% 14.0% 13.6% 16.5% YTD 30-Jun $ 194,234 43,109 237,343 7,580 14,516 259,439 30,219 -7,261 10,147 47,627 211,812 71,833 86,975 36,936 - 195,744 16,068 8,753 24,821 7,512 $ 17,309 $ 0.07 $ 0.07 247,047,007 252,436,239 81.6% 27.7% 33.5% 14.2% 75.4% 6.2% 30.3% 6.7% FY 2025 FY 2026 Cellebrite DI Ltd. Condensed and Consolidated - US GAAP Income Statements (U.S. Dollars in thousands, except share and per share data - unaudited) Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec Quarter Ended 31-Mar 30-Jun Revenue: Subscription services $ 76,688 $ 80,814 $ 84,195 $ 89,068 $ 96,549 $ 97,685 Term-license Total subscription Other non-recurring* Professional services Total revenue Cost of revenue: Subscription services Term-license Other non-recurring* Professional services Total cost of revenue Gross profit Operating expenses: Research and development Sales and marketing General and administrative Other Total operating expenses Operating income (loss) Financial income (expense), net Income (loss) before taxes on income Tax expense (income) 19,141 22,147 28,531 26,426 95,829 102,961 112,726 115,494 4,411 3,292 5,504 4,564 7,309 7,023 7,799 8,763 107,549 113,276 126,029 128,821 8,432 8,522 10,005 10,502 - - - 87 3,301 3,198 4,791 4,327 5,757 5,957 5,518 4,775 17,490 17,677 20,314 19,691 90,059 95,599 105,715 109,130 27,277 28,611 28,124 29,865 38,768 38,685 38,800 38,561 11,746 13,886 19,801 19,899 - - - - 77,791 81,182 86,725 88,325 12,268 14,417 18,990 20,805 7,060 6,374 5,298 5,466 19,328 20,791 24,288 26,271 1,928 1,315 4,099 5,010 21,304 21,805 117,853 119,490 3,668 3,912 6,780 7,736 128,301 131,138 14,238 15,981 - - 3,497 3,764 4,685 5,462 22,420 25,207 105,881 105,931 35,872 35,961 43,222 43,753 17,668 19,268 - - 96,762 98,982 9,119 6,949 4,515 4,238 13,634 11,187 2,696 4,816 Net Income (loss) Basic net earnings (loss) per share Diluted net earnings (loss) per share Pro-forma weighted average number of shares used to compute basic net earnings per $ 17,400 $ 0.07 $ 0.07 $ 19,476 $ $ 0.08 $ $ 0.08 $ 20,189 $ 0.08 $ 0.08 $ 21,261 0.09 0.08 $ 10,938 $ 0.04 $ 0.04 $ 6,371 $ 0.03 $ 0.02 Yr Ended 31-Dec $ 209,751 70,663 280,414 13,561 31,135 325,110 19,219 6 13,766 20,240 53,231 271,879 84,386 110,813 43,443 - 238,642 33,237 (108,800) (75,563) 5,537 $ (81,100) $ (0.42) $ (0.43) 190,154,549 190,154,549 83.6% 26.0% 34.1% 13.4% 73.4% 10.2% -7.3% -24.9% share Pro-forma weighted average number of shares used to compute diluted net earnings per share Gross margin R&D % of total revenue S&M % of total revenue G&A % of total revenue Total Operating Expenses % of total revenues Operating margin Tax rate Net margin Note: This document should be read in conjunction with the Company's SEC Filings . *Other non-recurring revenue is composed of hardware sales, usage fees and perpetual licenses, and 237,246,654 240,358,573 243,508,803 245,282,244 249,302,220 248,980,462 249,719,713 251,501,118 83.7% 84.4% 83.9% 84.7% 25.4% 25.3% 22.3% 23.2% 36.0% 34.2% 30.8% 29.9% 10.9% 12.3% 15.7% 15.4% 72.3% 71.7% 68.8% 68.6% 11.4% 12.7% 15.1% 16.2% 10.0% 6.3% 16.9% 19.1% 16.2% 17.2% 16.0% 16.5% 246,470,084 247,617,591 252,077,487 252,788,652 84.9% 80.8% 29.7% 27.4% 34.3% 33.4% 13.8% 14.7% 77.8% 75.5% 7.1% 5.3% 19.8% 43.0% 8.5% 4.9% FY 2026 Quarter Ended Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec 31-Mar 30-Jun $ 76,688 $ 80,814 $ 84,195 $ 89,068 $ 96,549 $ 97,685 19,141 22,147 28,531 26,426 21,304 21,805 95,829 102,961 112,726 115,494 117,853 119,490 4,411 3,292 5,504 4,564 3,668 3,912 7,309 7,023 7,799 8,763 6,780 7,736 107,549 113,276 126,029 128,821 128,301 131,138 8,113 -3,044 8,143 -2,943 9,361 -5,095 9,115 87 4,243 5,583 5,764 5,030 4,590 16,740 16,850 19,486 18,035 10,237 -3,423 4,456 18,116 10,092 -3,690 5,231 19,013 90,809 96,426 106,543 110,786 110,185 112,125 24,198 35,694 25,388 35,281 24,762 35,136 25,800 34,638 8,946 9,533 10,675 13,850 68,838 70,202 70,573 21,971 26,224 35,970 7,060 6,374 5,298 29,031 32,598 41,268 1,928 1,315 4,099 (924) (510) (309) - - - - - - $ 26,179 $ 30,773 $ 36,860 $ 74,288 36,498 5,466 41,964 5,010 (260) - - 36,694 29,826 39,569 12,204 81,599 28,586 4,515 33,101 2,696 215 - - 29,446 39,955 12,919 82,320 29,805 4,238 34,043 4,816 465 - - $ 30,620 $ 29,692 FY 2025 FY 2024 FY 2023 Yr Ended 31-Dec $ 209,751 70,663 280,414 13,561 31,135 325,110 19,219 6 13,644 18,577 51,446 273,664 77,866 102,842 37,674 218,382 55,282 (108,800) (53,518) 5,537 633 -119,348 $ 60,926 $ 0.31 $ 0.28 190,154,549 206,194,081 84.2% 24.0% 31.6% 11.6% 67.2% 17.0% -9.2% 18.7% Yr Ended 31-Dec $ 271,028 82,007 353,035 17,285 30,883 401,203 26,004 -16,047 18,313 60,364 340,839 88,648 121,752 38,320 248,720 92,119 (332,890) (240,771) 7,023 (4,049) -349,604 $ 97,761 $ 0.45 $ 0.42 209,471,827 227,258,731 85.0% 22.1% 30.3% 9.6% 62.0% 23.0% -1.2% 24.4% Yr Ended 31-Dec $ 330,765 96,245 427,010 17,771 30,894 475,675 34,732 87 15,325 20,967 71,111 404,564 100,148 140,749 43,004 283,901 120,663 24,198 144,861 12,352 (2,003) - - $ 130,506 $ 0.54 $ 0.51 241,626,316 254,677,860 85.1% 21.1% 29.6% 9.0% 59.7% 25.4% 7.1% 27.4% YTD 30-Jun $ 194,234 43,109 237,343 7,580 14,516 259,439 20,329 -7,113 9,687 37,129 222,310 59,272 79,524 25,123 163,919 58,391 8,753 67,144 7,512 680 - - $ 60,312 $ 0.24 $ 0.23 247,047,007 259,390,445 85.7% 22.8% 30.7% 9.7% 63.2% 22.5% 12.2% 23.2% Cellebrite DI Ltd. Condensed and Consolidated - Non-GAAP Income Statements (U.S. Dollars in thousands, except share and per share data - unaudited) Revenue: Subscription services Term-license Total subscription Other non-recurring* Professional services Total revenue Cost of revenue: Subscription services Term-license Other non-recurring* Professional services Total cost of revenue Gross profit Operating expenses: Research and development Sales and marketing General and administrative Total operating expenses Non-GAAP operating income Financial Income, net Income (loss) before taxes on income Tax expense (income) Income tax adjustment One time tax income Finance expense (income) Non-GAAP net income Basic net earnings (loss) per share Diluted net earnings per share Pro-forma weighted average number of shares used to compute basic net earnings per $ 0.11 $ $ 0.10 $ 0.13 $ 0.12 $ 0.15 $ 0.14 $ 0.15 0.14 $ 0.12 $ 0.12 $ 0.12 $ 0.11 share Pro-forma weighted average number of shares used to compute diluted net earnings per share Gross margin R&D % of total revenue S&M % of total revenue G&A % of total revenue Total Operating Expenses % of total revenues Operating margin Tax rate Net margin Note: This document should be read in conjunction with the Company's SEC Filings . *Other non-recurring revenue is composed of hardware sales, usage fees and perpetual licenses, and was previously referred to "Perpetual license and other." Changing the name for this type of revenue reflects that perpetual license revenue has declined to relatively insignificant levels with hardware sales now representing the majority of this type of revenue. 237,246,654 240,358,573 243,508,803 245,282,244 252,456,562 252,713,944 256,157,437 257,274,507 84.4% 85.1% 84.5% 86.0% 22.5% 22.4% 19.6% 20.0% 33.2% 31.1% 27.9% 26.9% 8.3% 8.4% 8.5% 10.8% 64.0% 62.0% 56.0% 57.7% 20.4% 23.2% 28.5% 28.3% 3.5% 2.5% 9.2% 11.3% 24.3% 27.2% 29.2% 28.5% 246,470,084 247,617,591 259,252,345 259,522,205 85.9% 85.5% 23.2% 22.5% 30.8% 30.5% 9.5% 9.9% 63.6% 62.8% 22.3% 22.7% 8.8% 15.5% 23.9% 22.6% FY 2025 FY 2026 31-Mar Quarter Ended 30-Jun Quarter Ended 30-Sep 31-Mar 30-Jun $ 90,475 177,754 141,257 81,142 17,625 6,260 8,969 523,482 $ 179,223 146,053 146,908 93,127 23,489 7,772 9,537 606,109 $ 281,361 127,216 117,135 104,196 20,812 9,034 8,648 668,402 $ 133,689 140,777 154,602 72,739 25,799 5,732 7,528 540,866 $ 141,250 146,759 154,522 110,782 21,514 6,466 8,388 589,681 6,897 100,305 11,545 17,766 10,922 10,261 28,714 186,410 6,687 85,661 12,586 19,962 10,242 17,464 28,714 181,316 6,289 69,580 12,727 22,533 9,807 16,267 28,714 165,917 7,091 105,491 11,760 23,150 127,966 16,403 119,559 411,420 7,344 103,185 11,667 24,552 121,909 16,414 119,559 404,630 $ 709,892 $ 787,425 $ 834,319 $ 952,286 $ 994,311 $ 10,214 53,932 219,442 4,210 287,798 $ 10,587 67,969 227,177 4,236 309,969 $ 11,136 62,486 239,677 3,618 316,917 $ 10,868 79,652 255,095 4,596 350,211 $ 18,113 77,009 263,350 5,736 364,208 6,566 45,641 - - -6,393 58,600 6,852 44,096 - - -18,095 69,043 7,510 44,386 - - -17,821 69,717 23,179 50,147 - - -18,209 91,535 24,573 49,940 - - -17,493 92,006 $ 346,398 $ 379,012 $ 386,634 $ 441,746 $ 456,214 * -510,153 (85) 890 (147,464) 363,494 * -533,847 (85) 2,639 (127,988) 408,413 * -553,111 (85) 2,459 (107,800) 447,685 * -585,233 (85) 992 (75,600) 510,540 * -605,809 (85) 1,602 (69,229) 538,097 $ 709,892 $ 787,425 $ 834,319 $ 952,286 $ 994,311 FY 2024 FY 2023 Yr Ended 31-Dec $ 189,517 74,713 38,693 77,269 26,400 5,550 9,940 422,082 7,341 28,859 7,024 15,896 10,594 14,260 26,829 83,974 $ 506,056 $ 8,282 44,845 195,725 4,972 253,824 5,515 47,098 47,247 81,715 54,117 9,157 244,849 $ 498,673 * -(84,896) (85) 1,050 118,143 34,212 $ 532,885 Yr Ended 31-Dec $ 191,659 153,746 101,818 82,358 23,246 5,827 8,939 567,593 7,682 36,601 11,072 16,995 11,306 10,604 28,714 122,974 $ 690,567 $ 11,077 63,330 216,970 4,125 295,502 6,954 45,247 - - -6,844 59,045 $ 354,547 * -498,883 (85) 2,086 (164,864) 336,020 $ 690,567 Yr Ended 31-Dec $ 124,457 161,049 151,544 104,972 19,630 6,595 7,603 575,850 14,618 97,959 10,880 22,209 81,469 16,308 119,559 363,002 $ 938,852 $ 16,834 71,244 277,583 3,996 369,657 16,677 49,526 - - -18,674 84,877 $ 454,534 * -568,721 (85) 2,220 (86,538) 484,318 938,852 Cellebrite DI Ltd. Condensed and Consolidated - Balance Sheets (U.S. Dollars in thousands) ASSETS Current Assets Cash and cash equivalents Short-term deposits Marketable securities Trade receivables Prepaid expenses and other current assets Contract acquisition costs Inventories Total current assets Non-current assets Other non-current assets Marketable securities Deferred tax assets, net Property and equipment, net Intangible assets, net Operating lease right-of-use assets, net Goodwill Total non-current assets Total Assets Liabilities, redeemable convertible preferred shares and shareholders' equity (deficiency) Current Liabilities Trade payables Other accounts payable and accrued expenses Deferred revenues Operating lease liabilities Total current liabilities Long-term Liabilities Other long-term liabilities Long-term deferred revenues Restricted Sponsor Shares liability Price Adjustment Shares liability Derivative warrant liabilities Operating lease liabilities Total long-term liabilities Total Liabilities Shareholders' equity (deficiency) Share capital Additional paid-in capital Treasury stock, NIS 0.00001 par value; 41,776 ordinary shares Accumulated other comprehensive income (Accumulated deficit) Retained earnings Total shareholders' equity (deficiency) Total liabilities, redeemable convertible preferred shares and shareholders' equity (deficiency) * Less than US$ 1. Note: This document should be read in conjunction with the Company's SEC Filings. Yr Ended 31-Dec $ (81,100) 18,998 (1,106) 10,011 -(7,737) 5,125 34,102 29,715 55,531 2,271 46,114 (5,610) (9,211) 4,362 (4,196) -243 3,691 734 121 102,058 (5,231) (2,687) (55,317) 56,336 - -(15,641) (22,540) -19,142 2,623 21,765 101,283 589 87,645 $189,517 $ 10,047 $ - $ - $ 4,363 $ - $ - $ - Cellebrite DI Ltd. Condensed and Consolidated - Quarterly US GAAP Cash Flows (U.S. Dollars in thousands - unaudited) FY 2023 FY 2024 FY 2025 Yr Ended 31-Dec $(283,007) 30,575 (2,904) 10,607 -(10,736) (4,015) 110,664 65,889 173,051 (5,829) 22,317 (341) 3,201 5,335 (4,839) -982 2,755 17,586 880 132,171 (8,566) (2,043) (127,789) 59,971 -(2,748) (68,298) (149,473) 42 17,265 3,344 20,651 3,349 (1,207) 189,517 $ 191,659 $ 7,706 $ - $ - $ 1,884 $ 164,770 $ 113,136 $ 254,766 Yr Ended 31-Dec $ 78,326 44,892 (2,371) 11,867 554 (8,164) 75 - - -(15,781) 49,768 (6,936) 5,614 4,585 547 1,760 1,632 4,943 4,248 (2,015) 173,544 (13,225) -(321,231) 152,992 59,809 (147,456) 861 (268,250) -20,097 4,956 25,053 (69,653) 2,451 191,659 $124,457 $ (549) $ - $ - $ 11,154 $ - $ - $ - Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec FY 2026 YTD 30-Jun $ 17,309 29,633 (1,385) 15,920 -(3,529) (765) - - -(5,629) (12,874) 299 (613) 2,113 (1,660) -(715) 1,194 (3,495) 1,671 37,474 (6,109) (15,619) (124,625) 60,945 55,546 (15,278) 17,819 (27,321) -4,251 2,868 7,119 17,272 (479) 124,457 $141,250 $ 10,535 $ - $ - $ 2,219 $ - $ - $ - Quarter Ended 31-Mar 30-Jun Cash flows from operating activities: Net income (loss) Adjustments to reconcile net income to net cash provided by (used in) operating activities: $ 17,400 $ 19,476 $ 20,189 $ 21,261 $ 10,938 $ 6,371 Share-based compensation and RSU's Amortization of premium and discount and accrued interest on marketable securities Depreciation and amortization Disposal and write-off of property and equipment Interest income from short-term deposits Deferred tax assets, net Revaluation of derivative warrants Remeasurement of Restricted Sponsor Shares liability Remeasurement of Price Adjustment Shares liability (Increase) decrease in trade receivables Increase (decrease) in deferred revenue Decrease (increase) in other non-current assets Decrease (Increase) in prepaid expenses and other current assets Changes in operating lease assets Changes in operating lease liability Abandonment of right-of-use assets and disposal of leasehold Improvements (Increase) decrease in inventories (Decrease) increase in trade payables Increase (decrease) in other accounts payable and accrued expenses (Decrease) increase in other long-term liabilities Net cash provided by (used in) operating activities Cash flows from investing activities: Capital expenditures Purchase of intangible assets Investment in marketable securities Proceeds from maturities of marketable securities Proceeds from sales of marketable securities Payment related to business combination, net of cash acquired Short-term deposits, net Net cash (used in) provided by investing activities Cash flows from financing activities: Exercise of warrants, net Exercise of options to shares Proceeds from ESPP, net Net cash provided by financing activities Net (decrease) increase in cash and cash equivalents and restricted cash Net effect of currency translation on cash and cash equivalents Cash and cash equivalents and restricted cash at beginning of period 8,777 8,810 15,308 11,997 (523) (1,202) (488) (158) 2,631 2,592 2,703 3,941 - - - 554 (2,380) (2,303) (1,734) (1,747) (386) (1,387) (51) 1,899 - - - - - - - - - - - -1,721 (10,931) (11,225) 4,654 992 2,310 13,310 33,156 785 210 398 (8,329) 5,480 (2,748) 336 2,546 1,156 1,070 1,197 1,162 (1,179) (532) (892) 3,150 - - - 1,760 (10) (524) 882 1,284 (1,046) (166) 713 5,442 (12,152) 17,622 (8,032) 6,810 (388) 286 658 (2,571) 20,878 32,583 33,272 86,811 (2,339) (3,608) (3,322) (3,956) - - - -(129,956) (53,190) (12,057) (126,028) 27,419 32,204 58,597 34,772 - 31,166 - 28,643 - - - (147,456) (21,628) 34,005 20,570 (32,086) (126,504) 40,577 63,788 (246,111) - - - -2,493 12,624 3,958 1,022 1,127 1,202 1,309 1,318 3,620 13,826 5,267 2,340 (102,006) 86,986 102,327 (156,960) 822 1,762 (189) 56 191,659 90,475 179,223 281,361 14,384 15,249 (1,148) (237) 7,005 8,915 - - (1,793) (1,736) (750) (15) - - - - - - 32,441 (38,070) (20,861) 7,987 552 (253) (4,964) 4,351 1,055 1,058 (1,015) (645) - - 144 (859) (5,987) 7,181 (10,393) 6,898 277 1,394 19,885 17,589 (3,041) (3,068) (7,059) (8,560) (74,575) (50,050) 24,607 36,338 39,706 15,840 (15,278) 0 22,065 (4,246) (13,575) (13,746) - - 2,128 2,123 1,383 1,485 3,511 3,608 9,821 7,451 (589) 110 124,457 133,689 Cash and cash equivalents and restricted cash at end of period $ 90,475 $179,223 $281,361 $124,457 $133,689 $141,250 Supplemental cash flow information: Income taxes (received) paid $ 806 $ (8,879) $ 4,686 $ 2,838 $ 3,538 $ - $ 6,997 Purchase of property and equipment on suppliers' credit Purchase of intangible assets $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - Operating lease liabilities arising from obtaining right of use assets $ 813 $ 12,328 $ - $ (1,987) $ 1,150 $ 1,069 Reclassification of warrants from liability to equity Reclassification of Restricted Sponsor Shares from liability to equity Reclassification of Price Adjustment Shares from liability to equity Note: This document should be read in conjunction with the Company's SEC Filings. $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - FY 2026 Quarter Ended Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec 31-Mar 30-Jun $ 17,490 $ 17,677 $ 20,314 $ 19,691 $ 22,420 $ 25,207 750 827 - - - - $ 16,740 $ 16,850 $ 828 775 - 881 - - 19,486 $ 18,035 $ 692 3,612 - 18,116 $ 657 5,536 1 19,013 $ 90,059 $ 95,599 $ 105,715 750 827 828 - - - - - - 90,809 96,426 106,543 $ 109,130 775 881 - $ 110,786 $ $ $ $ $ 105,881 692 3,612 - 110,185 $ 105,931 657 5,536 1 $ 112,125 $ 77,791 $ 81,182 $ 86,725 $ 88,325 $ 96,762 $ 98,982 - - - - - - 8,027 7,983 926 931 - 2,066 - - $ 68,838 $ 70,202 $ 574 - - - - - 14,480 11,222 934 1,227 164 1,588 - - 70,573 $ 74,288 $ - - -13,692 1,362 109 - 81,599 $ - - -14,592 1,394 676 - 82,320 FY 2025 FY 2024 FY 2023 Yr Ended 31-Dec $ 53,231 1,733 - 52 $ 51,446 $ 271,879 1,733 - 52 $ 273,664 $ 238,642 -(345) -17,265 3,347 (7) - $ 218,382 Yr Ended 31-Dec $ 62,593 2,227 - 2 $ 60,364 $ 338,610 2,227 - 2 $ 340,839 $ 281,704 1,068 - -28,348 3,349 219 - $ 248,720 Yr Ended 31-Dec $ 75,172 3,180 881 - $ 71,111 $ 400,503 3,180 881 - $ 404,564 $ 334,023 574 - -41,712 4,018 3,818 - $ 283,901 YTD 30-Jun $ 47,627 1,349 9,148 1 $ 37,129 $ 211,812 1,349 9,148 1 $ 222,310 $ 195,744 - - -28,284 2,756 785 - $ 163,919 GAAP to Non - GAAP Reconciliations (U.S. Dollars in thousands, except share and per share data) GAAP cost of revenue: Cost of revenue Less: Share-based compensation expense Amortization of intangible assets Acquisition-related costs Non-GAAP cost of revenue GAAP gross profit: Gross profit Share-based compensation expense Amortization of intangible assets Acquisition-related costs Non-GAAP gross profit GAAP operating expenses: Operating expenses Less: Executive severance costs Issuance expenses Dividend participation compensation Share-based compensation expense Amortization of intangible assets Acquisition-related costs Capital loss from FA disposal Non-GAAP operating expenses FY 2026 Quarter Ended Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec 31-Mar 30-Jun $ $ 12,268 - - -8,777 926 - 21,971 $ $ 14,417 - - -8,810 931 2,066 26,224 $ $ 18,990 574 - -15,308 934 164 35,970 $ $ 20,805 - - -11,997 2,108 1,588 36,498 $ $ 9,119 - - -14,384 4,974 109 28,586 $ $ 6,949 - - -15,249 6,930 677 29,805 $ $ 17,400 - - - -8,777 926 -(924) - 26,179 $ $ 19,476 - - - -8,810 931 2,066 (510) - 30,773 $ $ 20,189 574 - - -15,308 934 164 (309) - 36,860 $ $ 21,261 - - - -11,997 2,108 1,588 (260) - 36,694 $ $ 10,938 - - - -14,384 4,974 109 215 - 30,620 $ $ 6,371 - - - -15,249 6,930 677 465 - 29,692 $ $ 17,400 (7,060) 1,928 2,631 - - -8,777 - 23,676 22.0% $ $ 19,476 (6,374) 1,315 2,592 - - -8,810 2,066 27,885 24.6% $ $ 20,189 (5,298) 4,099 2,703 574 - -15,308 164 37,739 29.9% $ $ 21,261 (5,466) 5,010 3,941 - - -11,997 1,588 38,331 29.8% $ $ 10,938 (4,515) 2,696 7,005 - - -14,384 109 30,617 23.9% $ $ 6,371 (4,238) 4,816 8,915 - - -15,249 677 31,790 24.2% 20,878 32,583 33,272 86,811 19,885 17,589 (2,339) (3,608) $ 18,539 $ 28,975 $ (3,322) (3,956) 29,950 $ 82,855 $ (3,041) 16,844 $ (3,068) 14,521 FY 2025 FY 2024 FY 2023 Yr Ended 31-Dec $ 33,237 -(345) -18,998 3,347 45 $ 55,282 $ (81,100) - -(345) -18,998 3,347 45 633 119,348 $ 60,926 $ (81,100) 108,800 5,537 10,011 -(345) -18,998 45 $ 61,946 19.1% 102,058 (5,231) $ 96,827 29.8% Yr Ended 31-Dec $ 56,906 1,068 - -30,575 3,349 221 $ 92,119 $ (283,007) 1,068 - - -30,575 3,349 221 (4,049) 349,604 $ 97,761 $ (283,007) 332,890 7,023 10,607 1,068 - -30,575 221 $ 99,377 24.8% 132,171 (8,566) $ 123,605 30.8% Yr Ended 31-Dec $ 66,480 574 - -44,892 4,899 3,818 $ 120,663 $ 78,326 574 - - -44,892 4,899 3,818 (2,003) - $ 130,506 $ 78,326 (24,198) 12,352 11,867 574 - -44,892 3,818 $ 127,631 26.8% 173,544 (13,225) $ 160,319 33.7% YTD 30-Jun $ 16,068 - - -29,633 11,904 786 $ 58,391 $ 17,309 - - - -29,633 11,904 786 680 - $ 60,312 $ 17,309 (8,753) 7,512 15,920 - - -29,633 786 $ 62,407 24.1% 37,474 (6,109) $ 31,365 12.1% GAAP to Non - GAAP Reconciliations (U.S. Dollars in thousands, except share and per share data) GAAP operating income (loss) Executive severance costs Issuance expenses Dividend participation compensation Share-based compensation expense Amortization of intangible assets Acquisition-related costs Non-GAAP operating income (loss) GAAP net income (loss) Executive severance costs One-time tax income Issuance expenses Dividend participation compensation Share-based compensation expense Amortization of intangible assets Acquisition related costs Income tax expense Finance expenses (income) Non-GAAP net income (loss) GAAP net income (loss) Financial (Income) expense Tax expense (income) Depreciation and amortization Executive severance costs Issuance expenses Dividend participation compensation Share-based compensation expense Acquisition-related costs Adjusted EBITDA Adjusted EBITDA margin Cash flows from operating activities Less: Capital expenditures Free Cash Flow Free Cash Flow margin Note: This document should be read in conjunction with the Company's SEC Filings. 17.2% 25.6% 23.8% 64.3% 13.1% 11.1% FY 2025 FY 2024 FY 2023 Yr Ended 31-Dec $ 172,154 112,247 40,709 $ 325,110 53.0% 34.5% 12.5% 100.0% 315,689 - 315,689 315,689 165,389 114,206 36,094 125% Yr Ended 31-Dec $215,531 134,921 50,751 $ 401,203 53.7% 33.6% 12.6% 100.0% 395,899 -395,899 395,899 214,565 134,061 47,273 124% Yr Ended 31-Dec $256,582 161,361 57,732 $ 475,675 53.9% 33.9% 12.0% 100.0% 480,760 16,078 464,682 480,760 256,380 166,440 57,940 116% FY 2026 Cellebrite DI Ltd. - Revenue Mix (U.S. Dollars in thousands - unaudited) Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec Quarter Ended YTD 30-Jun $ 135,255 90,125 34,059 $ 259,439 - 52.1% 34.7% 13.1% 100.0% 507,771 -507,771 507,771 267,414 175,072 65,285 117% 31-Mar 30-Jun Revenue by geography: Americas $ 56,531 $ 61,246 $ 72,805 $ 66,000 $ 66,006 $ 69,249 EMEA APAC 37,421 38,461 38,488 46,991 13,597 13,569 14,736 15,830 46,825 43,300 15,470 18,589 Total revenue $ 107,549 $ 113,276 $ 126,029 $ 128,821 $ 128,301 $ 131,138 Revenue % of total: Americas EMEA APAC Total revenue Annual recurring revenue (in thousands) Total ARR ARR related to acquisitions Organic ARR Annual recurring revenue (in thousands) America EMEA APAC Recurring revenue net dollar-based retention rate Note: This document should be read in conjunction with the Company's SEC Filings. 52.6% 54.0% 57.8% 51.2% 34.8% 34.0% 30.5% 36.5% 12.6% 12.0% 11.7% 12.3% 100.0% 100.0% 100.0% 100.0% 408,060 418,875 439,803 480,760 - - - 16,078 408,060 418,875 439,803 464,682 408,060 418,875 439,803 480,760 221,259 226,296 240,244 256,380 136,432 141,762 147,200 166,440 50,369 50,817 52,359 57,940 121% 120% 117% 116% 51.4% 52.8% 36.5% 33.0% 12.1% 14.2% 100.0% 100.0% 492,970 507,771 - - 492,970 507,771 492,970 507,771 261,090 267,414 170,930 175,072 60,950 65,285 115% 117%

View stock analysis, news, and events for Cellebrite Di Ltd.